AMENDMENT #1 TO SHARED SPACE ARRANGEMENTShared Space Arrangement • August 6th, 2024 • Omega Therapeutics, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledAugust 6th, 2024 Company IndustryThis Amendment #1 To Shared Space Arrangement (this “Amendment”) is made effective as of July 1, 2024, by and between OMEGA THERAPEUTICS, INC., a Delaware corporation (“Licensor” or “Tenant”), having an address of 140 First Street, Ste 501, Cambridge, MA 02141, and Metaphore Biotechnologies, Inc., (“Licensee” or “Space Occupant”), having an address of 140 First Street, Ste 502, Cambridge, MA 02141.
AMENDMENT #1 TO SHARED SPACE ARRANGEMENTShared Space Arrangement • August 6th, 2024 • Omega Therapeutics, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledAugust 6th, 2024 Company IndustryThis Amendment #1 To Shared Space Arrangement (this “Amendment”) is made effective as of July 1, 2024, by and between OMEGA THERAPEUTICS, INC., a Delaware corporation (“Licensor” or “Tenant”), having an address of 140 First Street, Ste 501, Cambridge, MA 02141, and Apriori Bio, Inc., (“Licensee” or “Space Occupant”), having an address of 140 First Street, Ste 502, Cambridge, MA 02141.
AMENDMENT #1 TO SHARED SPACE ARRANGEMENTShared Space Arrangement • August 6th, 2024 • Omega Therapeutics, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledAugust 6th, 2024 Company IndustryThis Amendment #1 To Shared Space Arrangement (this “Amendment”) is made effective as of July 1, 2024, by and between OMEGA THERAPEUTICS, INC., a Delaware corporation (“Licensor” or “Tenant”), having an address of 140 First Street, Ste 501, Cambridge, MA 02141, and Prologue Medicines, Inc. (formerly Flagship Labs 89, Inc.), (“Licensee” or “Space Occupant”), having an address of 140 First Street, Ste 502, Cambridge, MA 02141.